Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

6-EAPB

This article is a stubmissing:
Subjective Effects
Interactions
Tolerance
History & Culture
Legality
6-EAPB molecule structure6-EAPB molecule structure
Chemical Class

6-EAPB is an aminoalkylbenzofuran structurally similar to MDMA1 and 6-APB1. Its psychoactive profile is uncertain1, with sources describing it as potentially psychedelic1 and entactogenic1; according to users, benzofurans are used for their stimulant and empathogenic properties1. User reports describe 6-EAPB as less powerful or euphoric than 6-APB but more stimulating1, and the source states that scientific documentation of its pharmacological and toxicological effects is lacking1.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~50 mg
Light50-75 mg
Moderate75-100 mg
Strong100-150 mg
Heavy150+ mg

Duration

Onset20-40 minutes
After Effects1-10 hours
Total4-7 hours

Subjective Effects

Subjective Effects not written up yet

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Marquis(MQ)
white → purple2 → purple3
Mecke(ME)
white → black3
Mandelin(MD)
yellow2 → red3 → purple3 → black3
Robadope(RB)
orange1 → blue1
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

6-EAPB is reported to be a potent monoamine reuptake inhibitor2. It is also suspected to promote monoamine release, although available pharmacological knowledge is limited and the relative contributions of release and reuptake inhibition are uncertain. It has very low potency as an agonist at serotonin 5-HT2A receptors.

Pharmacokinetics

Absorption & half-lifenot documented yetMetabolitesnone documented yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Classified as habit-forming. As a suspected monoamine releaser and/or reuptake inhibitor with entactogenic properties, psychological addiction potential may be present, though specific data is limited.

Psychosis Risk

Visual and auditory hallucinations have been reported as negative effects. Aggressiveness and moodiness are also documented, though the frequency and severity of these effects remain poorly characterized due to limited pharmacological knowledge.

History & Culture

History & Culture not written up yet

Legality

Legality not written up yet

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the 6-EAPB article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.